688136 科興製藥
按盤價 
17.550 +0.470 (+2.752%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.060 | -11.081 | -4.856 | 5.157 | 11.014 |
| 總資產報酬率 ROA (%) | 0.570 | -6.143 | -3.013 | 3.713 | 7.846 |
| 投入資產回報率 ROIC (%) | 0.618 | -6.734 | -3.341 | 4.125 | 8.924 | 邊際利潤分析 |
| 銷售毛利率 (%) | 69.858 | 70.791 | 75.365 | 79.410 | 79.983 |
| 營業利潤率 (%) | 5.367 | -20.351 | -10.530 | 7.626 | 13.099 |
| 息稅前利潤/營業總收入 (%) | 7.805 | -18.179 | -9.434 | 7.832 | 14.763 |
| 淨利潤/營業總收入 (%) | 1.324 | -15.527 | -7.054 | 7.506 | 11.402 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 125.417 | 104.758 | 100.529 | 38.389 | 101.015 |
| 價值變動淨收益/利潤總額(%) | -16.271 | -2.602 | 2.282 | 59.240 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -11.701 | 1.476 | 0.363 | -2.483 | -0.436 | 償債能力分析 |
| 流動比率 (X) | 1.472 | 1.692 | 2.617 | 2.420 | 3.730 |
| 速動比率 (X) | 1.286 | 1.406 | 2.231 | 2.135 | 3.473 |
| 資產負債率 (%) | 45.992 | 46.198 | 42.938 | 32.461 | 22.669 |
| 帶息債務/全部投入資本 (%) | 40.844 | 40.121 | 35.786 | 22.333 | 14.827 |
| 股東權益/帶息債務 (%) | 142.095 | 146.148 | 175.534 | 338.666 | 573.941 |
| 股東權益/負債合計 (%) | 117.044 | 116.120 | 133.080 | 208.059 | 341.125 |
| 利息保障倍數 (X) | 2.602 | -7.340 | -8.318 | 20.022 | 8.582 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 88.489 | 87.480 | 92.144 | 96.756 | 96.863 |
| 存貨周轉天數 (天) | 143.645 | 195.562 | 211.192 | 194.229 | 185.425 |
| 備註： | 即時報價更新時間為 04/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
